Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Role of Ginkgo Biloba Extract in IUGR

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
StatusasBaigta
Rėmėjai
Assiut University

Raktažodžiai

Santrauka

The use of herbal medicinal products is increasing enormously in recent years, mainly among women, who use them for the most varied purposes, such as in menstrual problems, menopausal symptoms, mood disturbances and to strengthen their bones. Most of these benefits are due to the flavonoids present in these products. These flavonoids have anticarcinogenic, antiviral, antioxidant and antiinflammatory activities, as well as being used in the treatment of osteoporosis, menopausal symptoms and cardiovascular diseases . Besides the benefits from the consumption of flavonoids, little is known about their safety and potentially harmful toxic effects, such as mutagenicity and genotoxicity which might occur if taken in large doses . Safety of Ginkgo biloba during pregnancy or lactation was not criticized in literature. Roasted and raw ginkgo seed were not reported in the evidence-based medicine literature as being either safe or contraindicated in pregnancy or lactation. A higher incidence of postpartum hemorrhage was reported in the literature when associated with a 3-month ingestion of Ginkgo Biloba extract. Flavonoids are components of Ginkgo biloba L. (Ginkgoaceae), a medicinal plant widely used by the population . G. biloba has its origin in China, Korea and Japan where its fruits and leaves have been used as food and medicine for a long time.
The extract of G. biloba (EGb) is composed of different terpene trilactones, i.e., ginkgolides A, B, C, J and bilobalide, many flavonol glycosides, biflavones and alkylphenols . The major flavonoids in the extract are kaempferol, quercetin and isorhamnetin] whose metabolites were found in the blood of rats and in human urine after oral administration of EGb. Due to its actions as an anti-inflammatory and antioxidant, EGb has been largely used in the treatment of Alzheimer's disease, pre-menstrual syndrome, cerebrovascular insufficiency and peripheral arterial occlusive disease . In folk medicine, EGb is used as a vermifuge, to induce labor, for the treatment of bronchitis, chronic rhinitis, chilblains, arthritis and edema . The aim of this study was to evaluate the effect of oral supplementation of Ginkgo Biloba extract on the fetal weight as well as feto-maternal blood flow in cases of intrauterine growth restriction.

Datos

Paskutinį kartą patikrinta: 02/29/2016
Pirmasis pateikimas: 04/20/2015
Numatytas registravimas pateiktas: 04/22/2015
Pirmas paskelbtas: 04/23/2015
Paskutinis atnaujinimas pateiktas: 03/19/2016
Paskutinis atnaujinimas paskelbtas: 03/21/2016
Faktinė studijų pradžios data: 04/30/2014
Numatoma pirminio užbaigimo data: 09/30/2015
Numatoma studijų užbaigimo data: 11/30/2015

Būklė ar liga

Intrauterine Growth Restriction (IUGR)

Intervencija / gydymas

Drug: Ginkgo Biloba Extract group

Other: Placebo group

Fazė

Fazė 2

Rankų grupės

RankaIntervencija / gydymas
Active Comparator: Ginkgo Biloba Extract group
This group received Ginko Biloba, two tablets per day
Drug: Ginkgo Biloba Extract group
Placebo Comparator: Placebo group
This group received placebo two tablets per day .
Other: Placebo group

Tinkamumo kriterijai

Amžius, tinkami studijuoti 20 Years Į 20 Years
Tinkamos studijoms lytysFemale
Priima sveikus savanoriusTaip
Kriterijai

Inclusion Criteria:

- Pregnant women in their third trimester (28-30 weeks of gestation).

- Pregnant women whose pregnancy was complicated with intra uterine growth restriction (IUGR).

- Normal Doppler indices in uterine, umbilical and middle cerebral arteries at time of recruitment.

Exclusion Criteria:

- Multiple pregnancies,

- Hypertension,

- Fetal congenital anomalies,

- Previous history of congenital anomalies or chromosomal abnormalities.

- Diabetes Mellitus

- Premature pre-labor rupture of membranes

- Antepartum hemorrhage

Rezultatas

Pirminės rezultatų priemonės

1. Fetal weight (gm) [one and half year]

Antrinės rezultatų priemonės

1. Doppler blood flow changes in uterine arteries indices [one and half year]

2. Doppler blood flow changes in umbilical arteries indices [one and half year]

3. Doppler blood flow changes in middle cerebral artery indices [one and half year]

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge